Welcome to our dedicated page for Cerence SEC filings (Ticker: CRNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cerence Inc. (NASDAQ: CRNC) SEC filings page brings together the company’s regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. As a software company focused on conversational AI for automotive and transportation, Cerence uses its SEC filings to report material events, financial results, restructuring actions, and significant agreements.
Investors can use this page to access 8-K filings that announce quarterly and annual financial results, as well as presentations used on earnings calls. These filings often include discussions of revenue from software licenses and cloud-connected services, key performance indicators such as the percentage of worldwide auto production with Cerence technology, and commentary on the company’s AI platforms and product adoption. Other 8-Ks describe material events such as restructuring plans related to certain foreign operations, retention and equity award arrangements for senior executives, and notable transactions.
Cerence has also filed 8-Ks detailing the resolution of patent disputes and the execution of a cross-license agreement with Samsung, which resulted in a one-time lump sum payment, and disclosing the announcement of financial results for specific periods. These documents provide insight into the company’s intellectual property strategy and its approach to monetizing and protecting its technology.
On Stock Titan, SEC filings for CRNC are updated as they become available from EDGAR. AI-powered tools can help summarize lengthy disclosures, highlight key sections in annual and quarterly reports, and surface important items such as restructuring charges, executive compensation arrangements, and material agreements. Users interested in Cerence’s regulatory history, financial condition, and corporate actions can review 10-Ks, 10-Qs, 8-Ks, and other forms here, and use AI summaries to quickly understand the implications of each filing.
Cerence Inc. executive Jennifer Salinas, EVP Chief Admin Officer, received a sizable equity award. On January 9, 2026, she was granted 131,694 shares of common stock at a price of $12.35 per share, reported as an acquisition of non-derivative securities.
The grant is described as restricted stock units under a Restricted Stock Unit Agreement, with the shares vesting in three equal installments on October 1, 2026, October 1, 2027, and October 1, 2028. Following this grant, Salinas beneficially owns 720,027 shares of Cerence common stock directly.
Cerence Inc. CFO Antonio Rodriquez reported an equity award on a Form 4. On January 9, 2026, he was granted 131,694 shares of Common Stock, reflecting restricted stock units with a reported value of $12.35 per share.
The footnote explains this is a grant of Restricted Stock Units under a Restricted Stock Unit Agreement. The RSUs vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Rodriquez beneficially owned 575,246 shares of Cerence common stock, held directly.
Cerence Inc. (CRNC) reported an equity award to its Chief Executive Officer and director on a Form 4. On 11/21/2025, the executive acquired 552,766 shares of common stock at a price of $10.35 per share, classified as an acquisition transaction. Following this grant, the executive beneficially owns 1,458,753 shares of Cerence common stock in direct ownership.
The filing notes that this grant represents performance stock units (PSUs) achieved under the company’s FY25 plan, which are scheduled to vest in November 2027. This reflects a performance-based equity incentive aligning the CEO’s compensation with Cerence’s future results over the multi‑year performance period.
Cerence Inc. (CRNC) executive vice president and chief administrative officer reported acquiring 242,044 shares of common stock on 11/21/2025 at $10.35 per share. These shares reflect achieved performance stock units (PSUs) under the company’s fiscal 2025 plan that are scheduled to vest in November 2027.
Following this transaction, the officer beneficially owns 588,333 shares of Cerence common stock in direct ownership. The filing is made on Form 4 by a single reporting person and documents an equity-based compensation event rather than an open-market purchase.
Cerence Inc. (CRNC) reported an insider equity award for its CFO. On 11/21/2025, the chief financial officer acquired 166,821 shares of Cerence common stock at $10.35 per share, increasing beneficial ownership to 443,552 shares held directly. The filing explains that this grant represents achieved performance stock units under the FY25 plan, which are scheduled to vest in November 2027. This ties the executive’s compensation more closely to the company’s longer-term performance.
Cerence Inc. (CRNC) reported an equity award to its EVP and Chief Revenue Officer on a Form 4. On 11/21/2025, the executive acquired 49,905 shares of common stock at a price of $10.35 per share, reported as an acquired transaction. Following this award, the executive beneficially owns 161,780 shares of Cerence common stock in direct ownership.
The filing notes that this grant represents achieved performance stock units (PSUs) under the company’s FY25 plan, which are scheduled to vest in November 2027. This reflects part of the executive’s performance-based compensation structure tied to company goals over the fiscal 2025 period.
Cerence Inc. (CRNC)49,905 shares of Cerence common stock at $10.35 per share. After this transaction, the executive beneficially owns 254,886 shares directly.
The company notes this grant represents performance stock units (PSUs) achieved under the FY25 plan that are scheduled to vest in November 2027, tying the award to longer-term performance and retention.
Cerence Inc. (CRNC) reports fiscal 2025 revenue of
Cerence remains a major player in automotive conversational and generative AI, with its technologies shipped in more than 525 million vehicles to date and an estimated
The company is restructuring through its 2024 and 2025 plans to reduce operating expenses and focus on profitable growth, while continuing to invest heavily in R&D and cloud-connected AI offerings for global automakers and tier-one suppliers.
Cerence Inc. (CRNC) filed a current report to announce that it has released its financial results for the fiscal year ended September 30, 2025. The company distributed a detailed press release, attached as Exhibit 99.1, and an earnings release investor presentation, attached as Exhibit 99.2, to discuss its full-year performance. Both exhibits include non-GAAP financial measures along with explanations of these metrics and reconciliations to GAAP figures, giving investors additional ways to review the company’s results. The materials are furnished under Item 2.02 of the report and are not treated as filed for liability purposes.
Cerence Inc. announced a resolution of its patent disputes with Samsung through a cross‑license agreement. As part of the settlement, Samsung agreed to pay Cerence a one‑time lump sum of $49,500,000.
The agreement resolves two cases: “Samsung I,” filed October 13, 2023, and “Samsung II,” filed March 15, 2024. Samsung had asserted counterclaims in July 2024, and trials had been scheduled for October 2025 and April 2026. The cross‑license, reached on October 28, 2025, concludes the litigation path and provides Cerence with a defined cash inflow in place of uncertain trial outcomes.